Rankin DA, Haddadin Z, Lipworth L, Stahl AL, Fryzek J, Suh M , et al. 2022. Comparison of clinical presentations and burden of respiratory syncytial virus in infants across three distinct healthcare settings in Davidson County, Tennessee. Therapeut Adv Infect Dis 9(July 18):20499361221112171; doi: 10.1177/20499361221112171 . PMID: 35875809.
View Abstract
Publication: Manuscripts
/ Topics: Epidemiology
Ponder J, Rajagopal R, Singal M, Baker N, Patlewicz G , Roggen E, Cochrane S, Sullivan K. 2022. “In Litero” screening. Retrospective evaluation of clinical evidence to establish a reference list of human chemical respiratory sensitizers. Front Toxicol 4(Jul 15):916370; doi: 10.3389/ftox.2022.916370 . PMID: 35910543.
View Abstract
Publication: Manuscripts
/ Topics: Adverse outcome pathways (AOPs) , NAMs
Karmaus A, Mansouri K, To K, Blake B, Fitzpatrick J, Strickland J, Patlewicz G , Allen D, et al. 2022. Evaluation of variability across rat acute oral systemic toxicity studies. Toxicol Sci 188(1):34-47; doi: 10.1093/toxsci/kfac042 . PMID: 35426934.
View Abstract
Publication: Manuscripts
/ Topics: NAMs
Roell K, Koval LE, Boyles R, Patlewicz G , Ring C, Rider CV, Ward-Caviness C, Reif D, et al. 2022. Development of the intelligence and machine learning toolkit (TAME) for introductory data science, chemical-biological analyses, predictive modelling, and database mining for environmental health research. Front Toxicol 4(Jun 22):893924; doi: 10.3389/ftox.2022.893924 . PMID: 35812168.
View Abstract
Publication: Manuscripts
/ Topics: computational toxicology , Epidemiology , Exposure Assessment
Lea IA , Pham LL, Antonijevic T, Thompson C , Borghoff SJ . 2022. Assessment of the applicability of the threshold of toxicological concern for per- and polyfluoroalkyl substances. Regul Toxicol Pharmacol 133:105190, open access .
View Abstract
Publication: Manuscripts
/ Topics: PFAS , Toxicology
Lea IA , Pham LL, Antonijevic T, Thompson C , Borghoff SJ . 2022. Assessment of the applicability of the threshold of toxicological concern for per- and polyfluoroalkyl substances. Regul Toxicol Pharmacol 133(August):105190; doi: 10.1016/j.yrtph.2022.105190 . PMID: 35662637.
View Abstract
Publication: Manuscripts
/ Topics: PFAS
Henderson RG , Nguyen H. 2022. Pathways to the US supplement market: New Dietary Ingredient Notification and Generally Recognized as Safe Determination. Chapter 19 in: Ruthsatz M, Wong AW (eds), Nutrition, Health, and Disease: Regulatory Policy Matters. Regulatory Affairs Professionals Society, E-Book, 427 pp., ISBN: 978-1-947493-82-7.
Publication: Book Chapters
/ Topics: Toxicology
Patlewicz G . 2022. Editorial: Reflections of the QSAR2021 meeting. Comput Toxicol 22(May):100221; doi: 10.1016/j.comtox.2022.100221 . PMID: 35252631.
View Abstract
Publication: Manuscripts
/ Topics: computational toxicology , NAMs
Carlson LM, Angrish M, Shirke AV, Radke EG, Schulz B, Kraft A, Judson RS, Patlewicz G , et al. 2022. Systematic evidence map for over one hundred and fifty per- and polyfluoroalkyl substances (PFAS). Environ Health Perspect 130(5):56001; doi: 10.1289/EHP10343 . PMID: 35580034.
View Abstract
Publication: Manuscripts
/ Topics: PFAS
Patlewicz G , Worth AP, Yang C, Zhu T. 2022. Editorial: Advances and refinements in the development and application of threshold of toxicological concern. Front Toxicol 4(Apr 28):882321; doi: 10.3389/ftox.2022.882321 . PMID: 35573274.
View Abstract